Infinity Pharmaceuticals

Infinity Pharmaceuticals R&D Expenses

The Research & Development Expenses of Infinity Pharmaceuticals (INFIQ) as of Nov 20, 2026 is 32.41 M USD. In the previous year, Research & Development Expenses was 31.65 M USD — a change of 2.41% (higher).

R&D Expenses

32.41 MUSD

YoY

2.41%

Last updated:

Research & Development Expenses of Infinity Pharmaceuticals is 2022 32.41 M USD. Research & Development Expenses of Infinity Pharmaceuticals was 2021 31.65 M USD. It decreases by 2.41% higher compared to the previous year.

The Infinity Pharmaceuticals R&D Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D Expenses
Date
R&D Expenses
Jan 1, 2015
199.10 M USD
Jan 1, 2016
119.60 M USD
Jan 1, 2017
20.80 M USD
Jan 1, 2018
19.80 M USD
Jan 1, 2019
27.12 M USD
Jan 1, 2020
26.76 M USD
Jan 1, 2021
31.65 M USD
Jan 1, 2022
32.41 M USD
The Infinity Pharmaceuticals R&D Expenses history
YEARR&D ExpensesYoY
32.41 MUSD+2.41%
31.65 MUSD+18.26%
26.76 MUSD-1.31%
27.12 MUSD+36.95%
19.80 MUSD-4.81%
20.80 MUSD-82.61%
119.60 MUSD-39.93%
199.10 MUSD+38.65%
143.60 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Infinity Pharmaceuticals Stock analysis

What does Infinity Pharmaceuticals do? Infinity Pharmaceuticals Inc. is a biopharmaceutical company based in Cambridge, Massachusetts. It was founded in 2001 and focuses on the discovery and development of novel therapies for cancer and other serious diseases. Infinity Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Infinity Pharmaceuticals stock

Research & Development Expenses of Infinity Pharmaceuticals is 32.41 M USD in 2022.

Research & Development Expenses of Infinity Pharmaceuticals changed from 31.65 M USD to 32.41 M USD, representing a 2.41% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Research & Development Expenses Infinity Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

R&D expenses represent the costs incurred in researching and developing new products, services, or processes. High R&D spending can signal innovation and future growth potential.

Research & Development Expenses's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Research & Development Expenses's Infinity Pharmaceuticals historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Infinity Pharmaceuticals

All Key Metrics — Infinity Pharmaceuticals